InvestorsHub Logo
Followers 51
Posts 9026
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 03/23/2022 8:43:42 AM

Wednesday, March 23, 2022 8:43:42 AM

Post# of 13363
NEWS: MODERNA ANNOUNCES ITS COVID-19 VACCINE PHASE 2/3 STUDY IN CHILDREN 6 MONTHS TO UNDER 6 YEARS HAS SUCCESSFULLY MET ITS PRIMARY ENDPOINT


Moderna to seek regulatory approval for COVID shot for very young children

https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-its-COVID-19-Vaccine-Phase-23-Study-in-Children-6-Months-to-Under-6-Years-Has-Successfully-Met-Its-Primary-Endpoint/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News